Your browser doesn't support javascript.
loading
MuTAR study, Phase II, open-label study of erlotinib (E) treatment in patients (pts) with locally advanced or metastatic non-small cell lung cancer (mNSCLC) who present activating mutations (MUT+) in the tyrosine kinase (TKI) domain of the epidermal growth factor receptor (EGFR), assessed the efficacy of 1L in Portuguese pts with mNSCLC EGFR Mut.
Barata, F; Queiroga, H; Teixeira, E; Almodovar, M T; Parente, B; Soares, M.
Affiliation
  • Barata F; Assistente Hospitalar Graduado de Pneumologia, Centro Hospitalar e Universitário de Coimbra, Portugal. Electronic address: fjssbarata@gmail.com.
  • Queiroga H; Professor da Faculdade de Medicina do Porto, Assistente Hospitalar Sénior, Centro Hospitalar de S João, Portugal. Electronic address: hjqueiroga@gmail.com.
  • Teixeira E; Assistente Hospitalar Graduada de Pneumologia, Centro Hospitalar Lisboa Norte, Portugal. Electronic address: encarnacaoteixeira@gmail.com.
  • Almodovar MT; Assistente Hospitalar Graduada Pneumologia, Instituto Português Oncologia Lisboa Francisco Gentil, Rua Professor Lima, Basto, 1089 Lisboa, Portugal. Electronic address: mteresaasa@gmail.com.
  • Parente B; Assistente Hospitalar Sénior de Pneumologia, Centro Hospitalar Gaia/Espinho, Portugal. Electronic address: barbaraparente@gmail.com.
  • Soares M; Assistente Hospitalar de Oncologia Médica, IPOPORTOFG, Portugal. Electronic address: martasoares71@gmail.com.
Rev Port Pneumol (2006) ; 22(5): 287-8, 2016.
Article in En | MEDLINE | ID: mdl-27162148
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / ErbB Receptors / Erlotinib Hydrochloride / Lung Neoplasms / Mutation / Antineoplastic Agents Type of study: Clinical_trials Limits: Humans Country/Region as subject: Europa Language: En Journal: Rev Port Pneumol (2006) Year: 2016 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / ErbB Receptors / Erlotinib Hydrochloride / Lung Neoplasms / Mutation / Antineoplastic Agents Type of study: Clinical_trials Limits: Humans Country/Region as subject: Europa Language: En Journal: Rev Port Pneumol (2006) Year: 2016 Document type: Article